U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C18H23N5O8P.Ca
Molecular Weight 976.833
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUCLADESINE CALCIUM

SMILES

[Ca++].CCCC(=O)NC1=NC=NC2=C1N=CN2[C@@H]3O[C@@H]4COP([O-])(=O)O[C@H]4[C@H]3OC(=O)CCC.CCCC(=O)NC5=NC=NC6=C5N=CN6[C@@H]7O[C@@H]8COP([O-])(=O)O[C@H]8[C@H]7OC(=O)CCC

InChI

InChIKey=RCFZVVHQICKFQW-NGVPHMJWSA-L
InChI=1S/2C18H24N5O8P.Ca/c2*1-3-5-11(24)22-16-13-17(20-8-19-16)23(9-21-13)18-15(30-12(25)6-4-2)14-10(29-18)7-28-32(26,27)31-14;/h2*8-10,14-15,18H,3-7H2,1-2H3,(H,26,27)(H,19,20,22,24);/q;;+2/p-2/t2*10-,14-,15-,18-;/m11./s1

HIDE SMILES / InChI
Bucladesine is a cyclic nucleotide derivative which mimics the action of endogenous cAMP and is a phosphodiesterase inhibitor. The compound is used in a wide variety of research applications because it mimics cAMP and can induce normal physiological responses when added to cells in experimental conditions. cAMP is only able to elicit minimal responses in these situations. The neurite outgrowth instigated by bucladesine in cell cultures has been shown to be enhanced by nardosinone. Recently, the effect of bucladesine as a cAMP analog has been studied on the pentylenetetrazol-induced seizure in the wild-type mice. The data showed that bucladesine (300nM/mouse) reduced the seizure latency and threshold. In addition they found that combination of bucladesine and pentoxyfillin has additive effect on seizure latency and threshold. Bucladesine is more lipophilic than cAMP and in contrast to cAMP capable of penetrating cell membranes. Bucladesine interferes with different protein kinases which are normally activated by cAMP. Bucladesine has undergone in the past clinical developments as systemic treatment for cardioprotection and as topical treatment to improve wound healing. In Japan, a bucladesine ointment (Actosin® ointment; Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan) was marketed to treat skin ulcers. Clinical studies have shown favourable effects on diabetic foot ulcers or decubitus, but the compound was later withdrawn despite good tolerability. One possible reason for the withdrawal may be the odour of the cream formulation which can be related to the hydrolytic cleavage in aqueous solutions resulting in release of butyric acid.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Myelin contributes to the parallel orientation of axonal growth on white matter in vitro.
2001
A cyclic AMP-regulated negative feedforward system for neuritogenesis revealed in a neuroblastomaxglioma hybrid cell line.
2001
Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity.
2001 Apr
Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes.
2001 Apr
Effect of the blood substitute diaspirin crosslinked hemoglobin in rat mesenteric and human radial collateral arteries.
2001 Apr
Up-regulation of cyclooxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids.
2001 Apr
Gonadotrophins inhibit and activin induces expression of inhibin/activin beta(B) subunit mRNA in cultured human granulosa-luteal cells.
2001 Apr
The water channel aquaporin-8 is mainly intracellular in rat hepatocytes, and its plasma membrane insertion is stimulated by cyclic AMP.
2001 Apr 13
Meiotic maturation of the mouse oocyte requires an equilibrium between cyclin B synthesis and degradation.
2001 Apr 15
Cyclic AMP- and IL6-signaling cross talk: comodulation of proliferation and apoptosis in the 7TD1 B cell hybridoma.
2001 Apr 15
A gap-junction-mediated signal, rather than an external paracrine factor, predominates during meiotic induction in isolated mouse oocytes.
2001 Feb
Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.
2001 Feb
Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes.
2001 Jan
The effects of histamine on interferon gamma production are dependent on the stimulatory signals.
2001 Jan
Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells.
2001 Jan-Feb
Shear stress regulates occludin content and phosphorylation.
2001 Jul
Modulation of alpha-ENaC and alpha1-Na+-K+-ATPase by cAMP and dexamethasone in alveolar epithelial cells.
2001 Jul
Distinct effect of diazoxide on insulin secretion stimulated by protein kinase A and protein kinase C in rat pancreatic islets.
2001 Jul
Molecular dynamics of point mutated I-A(k) molecules expressed on lymphocytes.
2001 Jul 2
Promoter regulatory elements and DNase I-hypersensitive sites involved in serglycin proteoglycan gene expression in human erythroleukemia, CHRF 288-11, and HL-60 cells.
2001 Jul 6
Modulation of thapsigargin-induced calcium mobilisation by cyclic AMP-elevating agents in human lymphocytes is insensitive to the action of the protein kinase A inhibitor H-89.
2001 Jun
Serine protease inhibitor causes F-actin redistribution and inhibition of calcium-mediated secretion in pancreatic acini.
2001 Jun
An immortalized jimpy oligodendrocyte cell line: defects in cell cycle and cAMP pathway.
2001 Jun
Cold suppression of follicle-stimulating hormone activity on proliferation and survival of newt spermatogonia.
2001 Jun
Helicobacter pylori induces pepsinogen secretion by rat gastric cells in culture via a cAMP signal pathway.
2001 Jun
Differential effects of apical and basolateral uridine triphosphate on intestinal epithelial chloride secretion.
2001 Jun
Inhibitor of nuclear factor-kappaB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expression.
2001 Jun 1
Aromatase expression in prepuberal Sertoli cells: effect of thyroid hormone.
2001 Jun 10
Peroxisomes exist in growth cones and move anterogradely and retrogradely in neurites of PC12D cells.
2001 Jun 10
Characterization of a steroidogenic factor-1-binding site found in promoter of sterol carrier protein-2 gene.
2001 Mar
Quantitative analysis of the proliferation of epidermal cells using a human skin organ culture system and the effect of DbcAMP using markers of proliferation (BrdU, Ki-67, PCNA).
2001 Mar
Stimulation by nitric oxide of gastric acid secretion in bullfrog fundic mucosa in vitro.
2001 Mar
Stimuli that induce a cholinergic neuronal phenotype of NG108-15 cells upregulate ChAT and VAChT mRNAs but fail to increase VAChT protein.
2001 Mar 1
Interactions of cyclic AMP and its dibutyryl analogue with model membrane: X-ray diffraction and Raman spectroscopic study using cubic liquid-crystalline phases of monoolein.
2001 Mar 15
Dual effect of cAMP on the writhing response in mice.
2001 Mar 30
The role of cyclic AMP in the pathogenesis of glucose desensitization in rat pancreatic islets.
2001 May
Hypoxia reverses dibutyryl-cAMP-induced stellation of cultured astrocytes via activation of the endothelin system.
2001 May
The properties of ryanodine-sensitive Ca(2+) release in mouse gastric smooth muscle cells.
2001 May
Impact of epididymal maturation on the tyrosine phosphorylation patterns exhibited by rat spermatozoa.
2001 May
The Drosophila melanogaster homologue of an insect calcitonin-like diuretic peptide stimulates V-ATPase activity in fruit fly Malpighian tubules.
2001 May
Effects of cyclic adenosine-monophosphate on growth and PSA secretion of human prostate cancer cell line.
2001 May
The influence of cAMP before or during bovine oocyte maturation on embryonic developmental competence.
2001 May 1
Overexpression of rat neuronal calcium sensor-1 in rodent NG108-15 cells enhances synapse formation and transmission.
2001 May 1
Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists.
2001 May 1
Reactive nitrogen species inhibit alveolar epithelial fluid transport after hemorrhagic shock in rats.
2001 May 15
Multiple transcription factors regulate the inducible expression of the human complement receptor 2 promoter.
2001 May 15
Nitric oxide regulates actin reorganization through cGMP and Ca(2+)/calmodulin in RAW 264.7 cells.
2001 May 28
Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype.
2001 May 28
GATA DNA-binding protein expressed in mouse I-10 Leydig testicular tumor cells.
2001 May 4
Effects of diabetes and insulin on hepatic delta6 desaturase gene expression.
2001 May 4
Patents

Patents

Name Type Language
BUCLADESINE CALCIUM
Common Name English
CALCIUM N6-2'-O-DIBUTYRYL CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE
Common Name English
ADENOSINE, N-(1-OXOBUTYL)-, CYCLIC 3',5'-(HYDROGEN PHOSPHATE) 2'-BUTANOATE, CALCIUM SALT (2:1)
Systematic Name English
Bucladesine calcium [WHO-DD]
Common Name English
Code System Code Type Description
FDA UNII
7J3JCE9A9U
Created by admin on Sat Dec 16 15:42:01 GMT 2023 , Edited by admin on Sat Dec 16 15:42:01 GMT 2023
PRIMARY
PUBCHEM
44514776
Created by admin on Sat Dec 16 15:42:01 GMT 2023 , Edited by admin on Sat Dec 16 15:42:01 GMT 2023
PRIMARY
SMS_ID
100000172823
Created by admin on Sat Dec 16 15:42:01 GMT 2023 , Edited by admin on Sat Dec 16 15:42:01 GMT 2023
PRIMARY
CAS
938448-87-4
Created by admin on Sat Dec 16 15:42:01 GMT 2023 , Edited by admin on Sat Dec 16 15:42:01 GMT 2023
PRIMARY